Cart
sales@molnova.com
USP8-IN-1
CAS No. 2477650-96-5
USP8-IN-1( —— )
Catalog No. M35341 CAS No. 2477650-96-5
USP8-IN-1 is an inhibitor of USP8 with an IC 50 of 1.9 μM. USP8-IN-1 inhibits H1975 cell growth with a GI 50 of 82.04 μM .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 464 | In Stock |
|
| 50MG | 641 | In Stock |
|
| 100MG | 923 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUSP8-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionUSP8-IN-1 is an inhibitor of USP8 with an IC 50 of 1.9 μM. USP8-IN-1 inhibits H1975 cell growth with a GI 50 of 82.04 μM .
-
DescriptionUSP8-IN-1 is a USP8 inhibitor with an IC50 of 1.9 μM. USP8-IN-1 inhibits H1975 cell growth with a GI50 of 82.04 μM (CN111138358A; U10).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorDUB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2477650-96-5
-
Formula Weight387.46
-
Molecular FormulaC18H21N5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (322.61 mM; Ultrasonic )
-
SMILESCOc1ccc(N2CCN(CC2)C(=S)Nc2ccc(cc2)[N+]([O-])=O)c(N)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhiyu Li, et al. USP8 inhibitor and preparation method and application thereof. CN111138358A.
molnova catalog
related products
-
USP8-IN-2
USP8-IN-2 is a potent inhibitor of the deubiquitinating enzymes USP7 and USP8, with an IC50 of 4.0 μM against USP8D. USP8-IN-2 is a potential compound for the treatment of cancer and viral infections.
-
USP15-IN-1
USP15-IN-1 is a potent USP15 inhibitor (IC50 is 3.76 μM) with high antiproliferative activity against non-small cell lung cancer and leukemia cells.
-
HBX 41108
HBx 41108 is a non-competitive, reversible inhibitor of USP7 with an IC50 of 424nM. HBx 41108 inhibited deubiquitination of p53 mediated by USP7 in a dose-dependent manner with an IC50 of 0.8μM.
